US 7582745
Compositions and methods for inhibiting expression of Nav1.8 gene
granted A61PA61P25/00A61P25/04
Quick answer
US patent 7582745 (Compositions and methods for inhibiting expression of Nav1.8 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P25/00, A61P25/04, A61P29/00, A61P43/00